Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Change in Cash (2021 - 2025)

Historic Change in Cash for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$1.6 million.

  • Cardio Diagnostics Holdings' Change in Cash fell 33960.62% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 36548.11%. This contributed to the annual value of $6.5 million for FY2024, which is 33090.93% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Change in Cash stood at -$1.6 million for Q3 2025, which was down 33960.62% from -$1.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Change in Cash registered a high of $9.3 million during Q2 2022, and its lowest value of -$4.8 million during Q4 2022.
  • Moreover, its 5-year median value for Change in Cash was -$96422.5 (2021), whereas its average is $356278.2.
  • The largest annual percentage gain for Cardio Diagnostics Holdings' Change in Cash in the last 5 years was 2719864.23% (2022), contrasted with its biggest fall of 728952.59% (2022).
  • Over the past 5 years, Cardio Diagnostics Holdings' Change in Cash (Quarter) stood at $526625.0 in 2021, then tumbled by 1020.29% to -$4.8 million in 2022, then soared by 51.59% to -$2.3 million in 2023, then skyrocketed by 349.13% to $5.8 million in 2024, then tumbled by 127.57% to -$1.6 million in 2025.
  • Its Change in Cash stands at -$1.6 million for Q3 2025, versus -$1.7 million for Q2 2025 and $1.9 million for Q1 2025.